Form 4: Clorox Director A.D. David Mackay Reports Acquisition of Deferred Stock Units

Director A.D. David Mackay reports the acquisition of deferred stock units in Clorox through dividend reinvestment and an annual award, increasing his holdings.

Summary

• A Form 4 filing reveals that A.D. David Mackay, a director at Clorox, acquired additional deferred stock units (DSUs) in the company.
• These acquisitions occurred through dividend reinvestments throughout the fiscal year and an annual award under the 2005 Stock Incentive Plan.
• Specifically, Mackay acquired 61.4293 DSUs on February 9, 2024, 66.1645 DSUs on May 10, 2024, 61.4205 DSUs on August 30, 2024, and 60.1979 DSUs on November 7, 2024, via dividend reinvestments.
• On December 31, 2024, Mackay received an annual award of 1,000.7162 DSUs.
• Following these transactions, Mackay's total holdings increased to 9,092.4019 DSUs.
• These DSUs will be settled in Clorox stock upon Mackay's retirement or termination of service as a director.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects standard regulatory filings related to director compensation. There are no explicit positive or negative implications for the company's performance.

Positives

• The acquisition of deferred stock units by a director signals confidence in the company's future performance.
• Dividend reinvestments indicate a long-term investment strategy by the director.

Future Outlook

The director's deferred stock units will be settled in Clorox stock upon retirement or termination of service.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and are a standard part of regulatory compliance. They provide transparency into the trading activities of company directors and officers.

Comparison to Industry Standards

• Director compensation packages often include deferred stock units to align the interests of management with those of shareholders.
• The specific amount and vesting schedule of DSUs can vary widely based on company size, industry, and individual performance.
• Comparing Mackay's DSU holdings and acquisition patterns to those of directors at peer companies like Procter & Gamble (PG) or Colgate-Palmolive (CL) could provide additional context.

Stakeholder Impact

• The increased holdings of a director can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates